Rewalk Robotics (RWLK) Stock Price Down 8.2%

Share on StockTwits

Rewalk Robotics Ltd (NASDAQ:RWLK) shares were down 8.2% during mid-day trading on Thursday . The company traded as low as $0.65 and last traded at $0.67. Approximately 667,218 shares changed hands during trading, an increase of 74% from the average daily volume of 383,973 shares. The stock had previously closed at $0.73.

Several analysts have recently commented on RWLK shares. Oppenheimer set a $2.00 price objective on shares of Rewalk Robotics and gave the company a “buy” rating in a report on Friday, August 24th. Zacks Investment Research downgraded shares of Rewalk Robotics from a “buy” rating to a “hold” rating in a report on Thursday, October 25th. One analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $1.85.

The firm has a market cap of $25.92 million, a P/E ratio of -0.68 and a beta of 0.77.

Rewalk Robotics (NASDAQ:RWLK) last released its quarterly earnings data on Thursday, November 8th. The medical device company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.01. The business had revenue of $1.62 million for the quarter, compared to the consensus estimate of $2.12 million. Rewalk Robotics had a negative net margin of 365.87% and a negative return on equity of 3,654.32%. Equities analysts expect that Rewalk Robotics Ltd will post -0.67 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was first posted by Week Herald and is the property of of Week Herald. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://weekherald.com/2018/11/10/rewalk-robotics-rwlk-stock-price-down-8-2.html.

Rewalk Robotics Company Profile (NASDAQ:RWLK)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.

Read More: Should You Consider an Index Fund?

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply